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[26_TD$DIFF]Abstract
In an attempt to combat the possibility of bacterial infection and insufficient bone
growth around metallic, surgical implants, bioactive glasses may be employed as
coatings. In this work, silica-based and borate-based glass series were synthesized
for this purpose and subsequently characterized in terms of antibacterial behavior,
solubility and cytotoxicity. Borate-based glasses were found to exhibit
significantly superior antibacterial properties and increased solubility compared
to their silica-based counterparts, with BRT0 and BRT3 (borate-based glasses
with 0 and 15 mol% of titanium dioxide incorporated, respectively) out-
performing the remainder of the glasses, both borate and silicate based, in these
respects. Atomic Absorption Spectroscopy confirmed the release of zinc ions
(Zn2+), which has been linked to the antibacterial abilities of glasses SRT0,
BRT0 and BRT3, with inhibition effectively achieved at concentrations lower
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than 0.7 ppm. In vitro cytotoxicity studies using MC3T3-E1 osteoblasts
confirmed that cell proliferation was affected by all glasses in this study, with
decreased proliferation attributed to a faster release of sodium ions over calcium
ions in both glass series, factor known to slow cell proliferation in vitro.
Keywords: Biomedical engineering, Materials science
1. Introduction
Titanium and some of its alloys (e.g. Ti6Al4[10_TD$DIFF]V and Ti6Al7Nb) is a common implant
material due to its ability to create a permanent bond to bone [11_TD$DIFF]via osseointegration [1,
2]. It has also been incorporated in bioactive glasses [3, 4, 5], to influence
crystallization mechanics of borosilicate glasses and to amend the solubility of both
phosphate and silicate glasses for medical applications. Titanium has also been used
in prosthetics, specifically, in direct skeletal attachment (DSA) [1], the method in
which metallic implants (typically made out of titanium or a titanium alloy) are
attached directly to the bone at the residual limb. After healing, the implant becomes
the attachment mechanism between the prosthesis and the body [6]. Concerns
regarding DSA include infection and skin irritation [7, 8, 9], with different
approaches taken towards re-designing DSA devices for improving patient outcomes.
These approaches usually involve modification of the surface by sandblasting,
plasma-spraying with either titanium or hydroxyapatite (HA), coating the implant
with a titanium dioxide (TiO2), or applying a coating made from bioactive glass [10,
11, 12]. HA coatings have been used clinically for more than 20 years due to its ability
to promote bone ingrowth [13, 14, 15]. However, HA coatings have nomechanism to
retard bacterial or biofilm colonization at the implant site. To address this deficiency,
some coatings have been produced based on chlorhexidine and silicone with
ammonia couplings [16, 17], but these have little clinical applicability as the active
compounds erode as they migrate to the surface. Bioactive glasses, on the contrary,
have shown encouraging results when used as coatings [11].
The development of 45S5 Bioglass® in the 1960s led to the potential of bioactive
glasses being used as coating materials [18], with Bioglass® being the first
synthetic material to chemically adhere to both hard and soft tissue [18, 19]. [12_TD$DIFF] n
situ degradation of such materials makes them desirable for clinical applications
owing to the release of beneficial ions into the physiological environment, which
can promote antibacterial behavior, bone formation and growth, and tissue
healing [20, 21, 22]. Though bioactive glasses have been used for coating metals,
compositions have contained aluminum [23, 24], associated with defective bone
mineralization and neurotoxicity [25], while other compositions have been
deficient in zinc [26, 27, 24, 28], an antibacterial component [22, 29, 30] that
aids the healing process by inhibiting the growth of bacteria, including caries-
related bacteria [13_TD$DIFF]Streptococcus mutans [31]. Although virtually all materials
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facilitate bacterial ingress which can lead to biofilm formation, bacteria attach
less readily to glass [32], making them a suitable option for coating surgical
implants. As bioactive glasses can be formulated to influence genetic expression,
differentiation and cell proliferation by the release of ions [21, 33, 34, 35],
control of the biological response through dissolution products creates an
opportunity for innovation. The current work considers two glass series, one
based on silica (SiO2) and one on borate (B2O3), with increasing amounts of
titanium dioxide (TiO2) incorporated at the expense of silica and borate,
respectively. B2O3 has been shown to reduce the coefficient of thermal expansion
(CTE) of glasses [36], so borate glasses have CTEs that better match the CTE of
the metallic substrate to be coated (typically Ti6Al4 [14_TD$DIFF]V, with a CTE of 10.6 ×
10−6/ °C in the range of 0–650 °C [37]). Coating such glasses into the metallic
substrates (e.g. through enameling [26, 38], plasma spraying [39] or electropho-
retic deposition [40]) requires heat treatment at temperatures high enough to
allow for the glass to react with the substrate surface thus creating a chemical
bond [41, 42]. After the bond has formed and the assembly brought back to room
temperature, a difference in CTE between the glass and metal will induce residual
stresses, evidenced by cracks appearing in the glass or at the glass/substrate
interface. For this reason, a borate-based glass series is proposed, to evaluate the
effect of B2O3 on its coating capability by means of a reduced CTE compared to
silica-based glasses, which means that residual stresses at the glass-substrate
interface would be reduced since both components would be subjected to
comparable amounts of shrinkage during the cool off stage of enameling. A
silica-based glass series is also proposed to allow for the evaluation of the effect
of B2O3 versus SiO2 on resultant properties of the coating. Furthermore, TiO2 is
incorporated to help promote a more stable chemical bond when coating onto
Ti6Al4 [10_TD$DIFF]V [36]; limited literature is currently available on the effect of TiO2
inclusion in borate-based glass structures. Calcium oxide (CaO) and phosphorus
pentoxide (P2O5) are also incorporated into the glasses as Ca and P are the main
elements in the inorganic phase of bone, hence helping in bone formation and
resorption [43]. Sodium oxide (Na2O) is included in the formulation as it has
been proven to reduce glass transition and crystallization temperature [44],
facilitating lower enameling temperatures, thus reducing the risk of α to β
transformation of the titanium substrate, a transformation which can hinder
corrosion resistance [37].
This study evaluates the characteristics of two new glass series, one silica-based
and one borate-based, in terms of their degradative behavior (including solubility
and ion release profiles), cytotoxicity, and in vitro antibacterial capabilities. For the
latter studies, inhibition zones were measured in media containing [15_TD$DIFF]Staphylococcus
epidermidis [16_TD$DIFF] and Escherichia coli.
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2. Materials and methods
2.1. Glass preparation
Silica-based and borate-based glasses (Table 1) in this study were previously
synthesized, and characterized structurally and mechanically as bulk and coating
material [45, 46]. TiO2 was added at the expense of SiO2 for the SRT series and at
the expense of B2O3 for the BRT series. The glasses were prepared by weighing
out appropriate amounts of analytical grade reagents (Fisher Scientific, Ottawa,
ON, Canada & Sigma-Aldrich, Oakville, ON, Canada), firing in silica crucibles [17_TD$DIFF]
(1400–1500°C for 1 h for the silica-based glasses, [18_TD$DIFF] 200°C for 1 h for borate-based
glasses), and shock quenching in water. The resulting frit was then ball-milled, and
sieved to retrieve glass particulates ≤20 μm.
2.1.1. Discs preparation
Approximately 200 mg of each glass were pressed using a hydraulic press with
pressure ranging between 17–20 MPa. The pressed discs were then heat treated to
promote the coalescence of glass particles and create a solid mass for
biocompatibility testing.
2.2. Solubility analysis
Three glass discs ( [19_TD$DIFF]n = 3) for each glass composition were placed in separate
containers filled with 25 mL of deionized water, and incubated at [20_TD$DIFF]37°C for 1, 7 and
30 days. The discs were weighted prior to incubation, and re-weighed after drying
after each incubation period; the percentage difference from the initial mass of the
disc was then computed as a function of time, per Eq. (1), as follows:
%ml tð Þ ¼ j
m0  m tð Þ
m0
j100% (1)
Table 1. Glass formulations (mol%).
Silica-based glass Borate-based glasses
Reagent SRT0 SRT1 SRT2 SRT3 BRT0 BRT1 BRT2 BRT3
SiO2 52 47 42 37 0 0 0 0
B2O3 0 0 0 0 52 47 42 37
CaO 12 12 12 12 12 12 12 12
P2O5 6 6 6 6 6 6 6 6
Na2O 14 14 14 14 14 14 14 14
ZnO 16 16 16 16 16 16 16 16
TiO2 0 5 10 15 0 5 10 15
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where %ml(t) is the percentage of mass loss, m0 is the mass at time zero (before
incubation) and m(t) is the mass at time t (where t = 1, 7 and 30 days).
2.3. Ion release through [21_TD$DIFF]Atomic Absorption Spectroscopy (AAS)
Samples for ion release profiles were prepared as described in subsection 2.2 and
measured using Atomic Absorption Spectroscopy (AAS), model PinAAcle 500
Flame Atomic Absorption Spectrometer (PerkinElmer, Waltham, MA, USA). AAS
calibration standards for titanium and zinc ions at concentrations of 0.00 (blank
sample), 0.50, 1.00, 5.00 and 10.00 ppm were prepared from stock solutions on a
gravimetric basis. At 1, 7 and 30 days, samples were tested, with the AAS
measuring absorbance levels, which were automatically translated into concentra-
tion levels by the Syngistix Touch software (PerkinElmer, Waltham, MA, USA)
based on the ion calibration curves.
2.4. pH change
Samples for pH change were prepared as described in subsection 2.2. At 1, 7 and
30 days, samples were tested using an Omega PHH222 pH meter (Omega, Laval,
QC, Canada) and compared to reference samples at t = 0 days to determine how
pH varied in the presence of the glass discs.
2.5. In vitro antibacterial analysis
The antimicrobial properties of the SRT and BRT glass discs were evaluated on
agar plates against prokaryotic species Escherichia coli (E.coli) and Streptococ-
cus epidermidis (S. epidermidis) against bacterial lawns, spread on Tryptic Soy
Agar (TSA) (3 g/L Tryptic Soy Broth, 15 g/L agar). All chemicals were
purchased from Fisher Scientific (Ottawa, ON, Canada). Bacterial cultures were
grown to an exponential phase (12–16 h), diluted in Physiological Saline Solution
(9 g/L NaCl) to 106 cells/mL and spread onto TSA. Antimicrobial properties were
quantified on the bacteria by measuring and comparing the zones of growth
inhibition. One disc of each glass was added to each bacterial plate (4 discs per
plate, evenly spaced on the lawn). Each plate had a single microbial species, and
each species was repeated in triplicate for statistical comparisons. The diameters
of the bacterial inhibition zones were measured at 1, 7 and 30 days, and the
means and standard deviations of triplicate samples were compared with the post-
hoc Tukey analysis of variance.
2.6. Cytotoxicity study
Bone metabolic activity assays were conducted to determine in vitro bioactivity
of the glasses. Pre-osteoblastic MC3T3-E1 cells (ATCC CRL-2593, ATCC,
Manassas, VA, USA) from passage 3–5 were used for this study and were
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maintained in αMEM media supplemented with 10% FBS and 1% (2 mM) L-
glutamine (Cambrex, MD, USA) within a cell culture incubator at 37° C/5% CO2/
95% air atmosphere. 24 well plates were seeded with cells at a density of 5,000
cells/cm2 and incubated for 24 hours prior to testing. Culture media (1 ml) was
then further supplemented with 100 μl of liquid extract (from the solubility
samples at 30 days for all glasses; n = 3 per sample well) and then incubated for
24 h at 37° C/5% CO2. 0.1 ml of MTT was added to the culture media. The
cultures were then re-incubated for 2 h (37° C/5% CO2) after which they were
removed from the incubator and the resultant formazan crystals dissolved by
adding an amount of MTT Solubilisation Solution (10% Triton x-100 in Acidic
Isopropanol (0.1 n HCl)) equal to the original culture medium volume. Once the
crystals were fully dissolved, the absorbance was measured at a wavelength of
570 nm. Cells seeded (at the same density) on tissue culture plastic (n = 3) were
used as controls.
2.7. Statistical methods
One-way analysis of variance (ANOVA) was employed to analyze the data to
determine significance in mean difference across the gathered data when p < 0.05.
Post-hoc Tukey and Dunnett tests were used on MiniTab 17 (MiniTab Inc., State
College, PA, USA). The Tukey test assumes equal variance in the data sets being
analyzed to determine the significance in mean difference across all factors (i.e. all
glasses in both series); the Dunnett test also assumes equal variance in the data, and
it is employed when a control group is used to compare against the data sets.
Results from the solubility analysis, pH change studies, AAS measurements and in
vitro antibacterial studies were analyzed using post-hoc Tukey; cytotoxicity results
were analyzed using post-hoc Dunnett.
3. Results
3.1. Solubility analysis
Evaluation of the mass loss at different incubation periods was undertaken, with
results shown in Fig. 1 (a) for the SRT glass series, and Fig. 1 (b) for the BRT
glass series. As a function of incubation period, it is observed that mass loss
steadily increased from day 1 to day 30, with SRT1 and BRT0 experiencing the
greatest amount of degradation within their respective series. Borate-based
glasses exhibited much higher degradation behavior than their silica-based
counterparts; additionally, crystallinity in the silica-based glasses may only
account for the reduced solubility of these glasses. As a function of incubation
period, for the SRT series, only SRT0 and SRT3 exhibited a significant increase
in solubility between 1 and 30 days (vs. all other SRT glasses), and SRT0 and
SRT3 between 1 and 7 days and between 7 and 30 days did not exhibit a
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significant difference in solubility; for the BRT series, all weight changes for all
glasses were statistically different, except for BRT0 and BRT2 between 1 and 7
days.
As a function of the amount of TiO2, no significant change in solubility is observed
as the amount of TiO2 is increased to 15 mol% for the silica-based glasses.
Similarly, for the borate-based glasses, a decrease in solubility is observed, but
only up to 10 mol% TiO2, with a significant increase for BRT3 (15 mol% TiO2) at
7 and 30 days.
[(Fig._1)TD$FIG]
Fig. 1. Solubility study for SRT (a) and for BRT (b) glass series. [3_TD$DIFF]n = 3; scatter bars indicate one
standard deviation from the mean. Stars and bars show statistical significance ( [4_TD$DIFF]p < 0.05).
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3.2. Ion release through [21_TD$DIFF]Atomic Absorption Spectroscopy (AAS)
Zn2+ release for the SRT series is shown in Fig. 2 (a), while results for the BRT
glass series are shown in Fig. 2 (b); Ti4+ release is shown in Fig. 3(a) and Fig. 3 (b)
for the SRT and BRT glass series, respectively. For both glass series, the inclusion
of TiO2 up to 10 mol% resulted in a significant drop in the concentration of Zn
2+
released; however, at 15 mol% an increase in Zn2+ release was observed. In terms
of incubation time, a significant increase in Zn2+ is observed for both glass series
at all incubation times, except for SRT2 between 1 and 7 days. With respect to Ti4+
release, for the SRT series an increase in release is observed with an increase in the
TiO2 content, which may be associated with a decrease in crystallinity for this
[(Fig._2)TD$FIG]
Fig. 2. Zn2+ release from SRT (a) and BRT (b) glass series. n = 3; scatter bars indicate one standard
deviation from the mean. Stars and bars show statistical significance (p < 0.05).
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series as TiO2 is increased (SRT3 is amorphous, while SRT1 and SRT2 exhibit
crystallinity) [45]; Ti4+ release in the BRT glasses increased with TiO2 content
incorporated into the glass, with a decrease observed for BRT3, glass which
exhibited a secondary crystal phase of TiO2 in XRD [45] explaining the decrease in
Ti4+ release. As a function of incubation time, all glasses exhibited statistically
different Ti4+ concentrations at each time.
[(Fig._3)TD$FIG]
Fig. 3. Ti4+ release from SRT (a) and BRT (b) glass series. [3_TD$DIFF]n = 3; scatter bars indicate one standard
deviation from the mean. Stars and bars show statistical significance ( [4_TD$DIFF]p < 0.05).
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3.3. pH change
Changes in the pH of deionized water were evaluated for the SRT and BRT
glasses, with results shown in Fig. 4. After 30-days incubation, no significant
difference is observed as a function of the amount of TiO2 incorporated for the
SRT series, with the SRT glasses averaging a pH of 7.90; due to the small standard
deviations in the measurements for the BRT series, only the pH at 30 days for
BRT0 and BRT3 are not significantly different. pH changes due to the BRT glasses
ranged between 8.67 and 8.85.
[(Fig._4)TD$FIG]
Fig. 4. pH Measurements for SRT (a) and for BRT (b) glass series. Control refers to samples prior to
incubation [3_TD$DIFF]n = 3; scatter bars indicate one standard deviation from the mean. Stars and bars show
statistical significance ( [4_TD$DIFF]p < 0.05).
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3.4. In vitro antibacterial analysis
Inhibition zones were measured for cultures of S. epidermidis and E. coli after 1, 7
and 30 days of incubation with SRT and BRT glass discs. Results are shown in
Fig. 5 for S. epidermidis inhibition by the SRT and BRT glasses, and in Fig. 6 for
E. coli inhibition by the BRT glasses. No inhibition zones were observed in the E.
coli cultures, with the exception of BRT0, which showed a small zone after 1 day,
but with the presence of bacteria in-growth in the zone, indicating resistance of the
E. coli bacteria to the antibacterial effect of BRT0.
[(Fig._5)TD$FIG]
Fig. 5. Inhibition zones (in mm) for [5_TD$DIFF]S. epidermidis for SRT (a) and BRT (b) glasses. BRT1 and BRT2
did not inhibit bacterial growth. [3_TD$DIFF]n = 3; scatter bars indicate one standard deviation from the mean. Stars
and bars show statistical significance ( [4_TD$DIFF]p < 0.05).
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Regarding S. epidermidis, the SRT glasses exhibited inhibition zones that remained
constant as a function of incubation time (with the exception of SRT1, which
started exhibiting antibacterial activity after 7 days, and SRT0 significantly
increased from day 1 to day 7). Greater inhibition zones were observed for the BRT
glasses, namely BRT0 and BRT3, with BRT0 proving to be the best antibacterial
glass from both glass series. BRT1 and BRT2 exhibited no inhibition zone.
Statistically, for S. epidermidis, all SRT glasses are significantly equivalent,
whereas for the BRT glasses only BRT1 and BRT2 (both glasses which exhibited
no antibacterial behavior) are significantly equivalent. For the BRT glasses, which
exhibited significant difference in antibacterial behavior with the addition of TiO2,
it was observed that including TiO2 in the glass network prevented the bacterial
growth inhibition, with the exception of BRT3, which inhibited the growth of
Gram-positive bacteria S. epidermidis.
3.5. Cytotoxicity study
Cell viability was assessed through an MTT assay for cytotoxicity, with results
reported in Fig. 7. Overall, a decrease in absorbance was observed for all glasses
when compared with the control, indicating a decrease in proliferation in the
presence of the glasses; nonetheless, glasses SRT1, SRT3 and BRT2 were found to
be statistically equivalent to the controls. Contrasting the SRT and BRT series, the
performance of both series could be described as similar, with SRT3 (10 mol%
TiO2 incorporated) exhibiting higher proliferation opposed to the other glasses;
however, all glasses were statistically equal in terms of cell viability among
themselves.
[(Fig._6)TD$FIG]
Fig. 6. Inhibition zones (in mm) for [6_TD$DIFF]E. coli for BRT glasses. BRT1 to BRT3 did not inhibit bacterial
growth. [3_TD$DIFF]n = 3; scatter bars indicate one standard deviation from the mean. Stars and bars show statistical
significance ( [4_TD$DIFF]p < 0.05).
Article No~e00420
12 http://dx.doi.org/10.1016/j.heliyon.2017.e00420
2405-8440/© 2017 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).
4. Discussion
From Fig. 1, it can be observed that the inclusion of TiO2 to both the silica-based
and the borate-based glass structures resulted in a decrease in solubility. For the
silica-based glasses, at 30 days, decreasing solubility with increasing TiO2 content
to up to 15 mol% can be observed, whereas for the borate-based glasses this trend
is observed only up to 10 mol% TiO2. BRT3 exhibited degradation behavior
comparable to that of the control BRT0, which may be attributed to TiO2 in BRT3
partially existing as a separate phase from the glass phase [45], which may explain
the increased solubility of these particular glass samples. In terms of overall
solubility, the borate-based glasses exhibited higher solubility compared to the
silica-based glasses, which was expected since borate-based glasses have been
shown to degrade faster than their silica-based counterparts due to their lower
chemical durability [48, 49, 47], making them a suitable option in applications
where faster dissolution of the coating is required. Degradation is also confirmed
through AAS, which recorded larger quantities of Zn2+ released from the control
glasses (SRT0 and BRT0) as opposed to their titanium-containing counterparts.
Borate-based structures allow for the release of the modifier ions more readily than
silica-based structures. Moreover, for BRT3, an increase in degradation is observed
when compared to BRT2, the amount of Ti4+ released did not follow this trend,
which, again, is to be attributed to the occurrence of TiO2 as a separate phase in the
glass, a phase which, due to its crystallinity, does not allow for titanium to be
released [50].
[(Fig._7)TD$FIG]
Fig. 7. MTT cytotoxicity assay results using 30-day incubation liquid extracts from SRT and BRT
glasses. [3_TD$DIFF]n = 3; scatter bars indicate one standard deviation from the mean. Stars and bars show statistical
significance ( [4_TD$DIFF]p < 0.05).
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As expected, exposure of the glass samples to deionized water resulted in an
increase in pH due to the release of ions altering the acidity of the media. With the
greater dissolution of the BRT series, pH was observed to increase more than in the
SRT series; however, at 30 days, it can be seen that the pH of the media for all
BRT glasses reached a maximum of 8.85. For the SRT series, which exhibited
much lower solubility, the pH reached a maximum of 8.05 for SRT2 after 30 days
incubating. A higher pH raise in borate-based glasses compared to silica-based
glasses has been previously reported [20]; furthermore, the substitution of SiO2
with TiO2 did not significantly affect pH, and substitution of B2O3 with TiO2 did
not result in a substantial change in pH after 30 days.
As an antibacterial agent, the amounts of Zn2+ measured through AAS at day 1 are
linked to the larger bacterial inhibition zones in BRT0 and BRT3 in the BRT series
and SRT0 in the SRT series for Gram-positive bacteria S. epidermidis, with the BRT
series significantly outranking the SRT series. The reduction in solubility due to the
addition of TiO2 translated into a reduction in release of Zn
2+
, and therefore the lack
of antibacterial behavior of glasses BRT1 and BRT2, with the sudden increase in
antibacterial behavior observed in BRT3 attributed to the occurrence of TiO2 as a
separate phase [45]. Additionally, the SRT glasses that exhibited antibacterial
behavior also showed signs of bacterial recolonization, evidencing the weak
antibacterial nature of these glasses. The proliferation of Gram-negative bacteria E.
coli was not significantly affected by the presence of any of the glasses. Gram-
positive bacterial growth is more likely to be inhibited when compared to Gram-
negative bacterial growth given that Gram-negative bacteria have a layer of
lipopolysaccharide (LPS) molecules, not present in Gram-positive bacteria, acting as
an impermeable layer against Zn2+ ingress [51, 52]. It has been shown that, for the
same concentration of zinc ions from zinc nanoparticles, inhibition zones for Gram-
negative bacteria are 16–33% smaller than those of Gram-positive bacteria [53]. In
fact, glass BRT0, which showed greater inhibition zones in the presence of gram-
positive bacteria S. epidermidis, was the only glass composition in this study that
exhibited an inhibition zone for Gram-negative E. coli. In the light of these results, it
would be expected that BRT0 would exhibit antibacterial behavior when tested in
vivo, tackling the issue of bacterial infection at the site of prosthetic implantation [7,
8, 9]. Further time-dependent tests in liquid or biofilm systems are necessary to
corroborate these antibacterial results in scenarios closer to in vivo environments.
When tested to determine the cell viability capacity of the glasses, it was determined
that all glasses slowed down the proliferation of MC3T3-E1 osteoblasts, which was
unexpected, as the levels of Zn2+ were not found to be toxic [54], indicating potential
toxicity of the borate ion (BO3)
3− for the BRT glasses, which has been found to occur
in vitro in borate-based glasses [55], while this toxicity has not been reported under
dynamic testing conditions [56]. Recognizing, though, that both glass series exhibited
comparable cytotoxic behavior, then inhibition of cell proliferation for both glasses
Article No~e00420
14 http://dx.doi.org/10.1016/j.heliyon.2017.e00420
2405-8440/© 2017 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).
may be more likely explained by a faster release of sodium (alkali ion) over calcium
(alkaline ion) [44, 57, 58], linked to the glass compositions possessing a higher Na2O
than CaO (14 mol% vs. 12 mol%).
Once an implant is inserted in the human body, two processes start to occur:
bacteria attempt to colonize it, while tissue integration from the surroundings
occurs; this phenomenon is known as “the race for the surface” [59, 60]. The
desirable outcome is that bacterial infection is inhibited, while tissue integration is
promoted; the antibacterial results herein presented present BRT0 and BRT3 as
potential candidates to eliminate bacteria at the implantation site, with their
superior antibacterial conditions potentially allowing for bone cells to attach and
proliferate around the implant in vivo.
5. Conclusions
Silica-based and borate-based glass series have been synthesized and their
antibacterial, solubility and cytotoxicity characteristics evaluated to determine their
potential for coating surgical implants. Overall, the borate-based glasses exhibited
significantly superior antibacterial and solubility behavior to the silica-based
glasses, with BRT0 and BRT3 (with 0 and 15 mol% of TiO2 incorporated,
respectively) outperforming the remainder of the glasses. Atomic Absorption
Spectroscopy confirmed the release of Zn2+ which is linked to the antibacterial
inhibition observed from glasses SRT0, BRT0 and BRT3 at concentrations lower
than 0.7 ppm, toxic to S. epidermidis and E. coli, with the reduction in solubility
due to TiO2 presence accounting for the decrease in Zn
2+ release in BRT1 and
BRT2, preventing these glasses from exhibiting antibacterial behavior. In vitro
cytotoxicity studies were conducted using MC3T3-E1 osteoblasts to evaluate how
cell proliferation was affected by the proposed glasses, with results indicating a
decrease in proliferation from glasses SRT0, SRT2, BRT0 and BRT1, which may
be attributed to a faster release of sodium ion over calcium ion in both glass series
for both glass series, factor known to slow cell proliferation in vitro. In vivo studies
are now required to evaluate the effect of a dynamic environment, as surgical
implants would be subjected to in the human body, on the cytotoxicity and
antibacterial inhibitory characteristics of these glasses.
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